PERINATAL CORE PROTOCOL FOR HIV INFECTED WOMEN (PACTG P1025, VERSION 20)
PERINATAL CORE PROTOCOL FOR HIV INFECTED WOMEN (PACTG P1025, VERSION 20)
批准号:
7606238
负责人:
MARK H MIROCHNICK
金额:
$1.4万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-03 至 2007-11-30
关键词:
CaringChildClinicalClinical Trials DesignComputer Retrieval of Information on Scientific Projects DatabaseConduct Clinical TrialsDataEffectivenessEpidemicEpidemiologic StudiesFundingGrantHIVHIV InfectionsInfantInstitutionInterventionLaboratoriesMaternal HealthMissionModificationPerinatalPregnancyPregnant WomenProtocols documentationRecruitment ActivityResearchResearch PersonnelResourcesSafetySiteSourceTimeUnited States National Institutes of HealthVertical Disease TransmissionWomanbaseimprovedprevent
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Although the major mission of the PACTG has traditionally been to conduct clinical trials, at this time in the epidemic of HIV-infection in child-bearing women, it is both appropriate and necessary for the PACTG to recruit pregnant women into a non-interventional, analytic, epidemiologic study in order to methodically collect clinical and laboratory data from the women and their infants. In this way, the PACTG can achieve the important aims of evaluating managment of HIV-infected women during pregnancy and determining the safety and effectiveness of ART and other interventions intended to prevent vertical transmission and/or improve maternal health. PACTG 367 has demonstrated that data can be collected prospectively from women and their infants receiving care at PACTG sites. Furthermore, these data can be analyzed on an ongoing basis to provide important information used not only for the design of clinical trials, but also for modification of clinical care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Safety Pharmacokinetics & Efficacy of Artemether & Lumefantrine in Pregnant Women
-
批准号:7360186
-
项目类别:
-
资助金额:$12.32万
-
财政年份:2008
-
负责人:MARK H MIROCHNICK
-
依托单位:
PHARMACOKINETICS OF ANTIRETROVIRAL DRUGS IN PREGNANT HIV INFECTED WOMEN
-
批准号:7606254
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2007
-
负责人:MARK H MIROCHNICK
-
依托单位:
ANTIRETROVIRAL DRUGS DURING PREGNANCY, SUBSTUDY OF PACTG P1025
-
批准号:7606233
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2007
-
负责人:MARK H MIROCHNICK
-
依托单位:
PERINATAL CORE PROTOCOL FOR HIV INFECTED WOMEN (PACTG P1025, VERSION 20)
-
批准号:7379492
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2005
-
负责人:MARK H MIROCHNICK
-
依托单位:
Antiretroviral Pharmacology/Lactating Mother/Infants
-
批准号:7006344
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2005
-
负责人:MARK H MIROCHNICK
-
依托单位:
ANTIRETROVIRAL DRUGS DURING PREGNANCY, HIV INFECTED WOMEN (SUB OF PACTG P1025)
-
批准号:7379485
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2005
-
负责人:MARK H MIROCHNICK
-
依托单位:
Antiretroviral Pharmacology/Lactating Mother/Infants
-
批准号:7140599
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2005
-
负责人:MARK H MIROCHNICK
-
依托单位:
ANTIRETROVIRAL DRUGS DURING PREGNANCY IN HIV POSITIVE FEMALES
-
批准号:7206283
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2004
-
负责人:MARK H MIROCHNICK
-
依托单位:
PERINATAL CORE PROTOCOL IN HIV INFECTED WOMEN (PACTG P1025, VERSION 20)
-
批准号:7206292
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2004
-
负责人:MARK H MIROCHNICK
-
依托单位:
PERINATAL CORE PROTOCOL (PACTG P1025, VERSION 2.0)
-
批准号:7042216
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2003
-
负责人:MARK H MIROCHNICK
-
依托单位:
ACTG 316, V 1--NEVIRAPINE VERSUS NEVIRAPINE PLACEBO IN PREGNANT HIV WOMEN
-
批准号:6306716
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1999
-
负责人:MARK H MIROCHNICK
-
依托单位:
ACTG 353, V 2--NELFINAVIR COADMINISTERED W/ ZIDOVUDINE & LAMIVUDINE
-
批准号:6264937
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:MARK H MIROCHNICK
-
依托单位:
ACTG 316, V 1--NEVIRAPINE VERSUS NEVIRAPINE PLACEBO IN PREGNANT HIV WOMEN
-
批准号:6264928
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1998
-
负责人:MARK H MIROCHNICK
-
依托单位:
DETERMINATIONS OF CANNABINOIDS IN MECONIUM
-
批准号:6123274
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MARK H MIROCHNICK
-
依托单位:
RECOMBINANT HIV 1 ENVELOPE ANTIGEN IN CHILDREN BORN TO HIV INFECTED MOTHERS
-
批准号:6278420
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1997
-
负责人:MARK H MIROCHNICK
-
依托单位:
HIVIG IN THE PREVENTION OF MATERNAL FETAL TRANSMISSION OF HIV
-
批准号:6248476
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MARK H MIROCHNICK
-
依托单位:
RECOMBINANT HIV 1 ENVELOPE ANTIGEN IN CHILDREN BORN TO HIV INFECTED MOTHERS
-
批准号:6248485
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1997
-
负责人:MARK H MIROCHNICK
-
依托单位:
HIVIG IN THE PREVENTION OF MATERNAL-FETAL TRANSMISSION OF HIV
-
批准号:5220637
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARK H MIROCHNICK
-
依托单位:--
RECOMBINANT HIV 1 ENVELOPE ANTIGEN IN CHILDREN BORN TO HIV INFECTED MOTHERS
-
批准号:6117225
-
项目类别:
-
资助金额:$3.86万
-
财政年份:--
-
负责人:MARK H MIROCHNICK
-
依托单位:
ACTG 353, V 2--NELFINAVIR COADMINISTERED W/ ZIDOVUDINE & LAMIVUDINE
-
批准号:6306725
-
项目类别:
-
资助金额:$3.05万
-
财政年份:--
-
负责人:MARK H MIROCHNICK
-
依托单位:
海外基金